Browsing "Journal Papers" by Journal : European journal of cancer (Oxford, England : 1990)

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 11 of 11

Pub YearTitleAuthor(s)
2022237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)안미선
2022258 (PB038) - SORT1 with oncogenic potential associated hypomethylation and promotes tumor progression in hepatocellular carcinoma김순선, 은정우, 정재연, 조효정, 한지은
2022295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma김순선, 은정우, 정재연, 조효정, 한지은
2022344 (PB124) - Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma조효정
2023A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)안미선
2022Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response김석휘
2021Corrigendum to ‘Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer’, [Eur J Canc 51 (2015) 482–488]강석윤
2021Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report정용식, 한세환
2021Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)이현우
2015Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer.강석윤
2012TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid박태준, 임인경
1

Browse